Sclerostin as a novel marker of bone turnover in athletes
Sclerostin is a protein secreted by osteocytes that acts as an inhibitor of bone formation. It has been shown that physical activity affects sclerostin concentration and thus bone remodelling. The aim of the study was to evaluate serum concentrations of sclerostin, selected bone turnover markers (PT...
Saved in:
Main Authors: | A Zagrodna (Author), P Jóźków (Author), M Mędraś (Author), M Majda (Author), M Słowińska-Lisowska (Author) |
---|---|
Format: | Book |
Published: |
Termedia Publishing House,
2016-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the relationship between inflammation and bone turnover by sclerostin and Dickkopf-1 (DKK-1) levels in patients with SIRS
by: Mehmet Aşık, et al.
Published: (2022) -
Sclerostin - a potential new marker of exercise influence on vascular calcification and mineral and bone disorder in hemodialysed adults
by: Agnieszka Turon-Skrzypinska, et al.
Published: (2019) -
Sclerostin inhibition: A novel target for the treatment of postmenopausal osteoporosis
by: Suruchi Aditya, et al.
Published: (2021) -
Effects of Alendronate and Raloxifene on Bone Density and Bone Turnover Markers in Postmenopausal Women
by: Ebru Zülfikaroğlu, et al.
Published: (2011) -
Anti-sclerostin antibody - A potential therapeutic target for periodontal bone regeneration
by: Shruthi Reghunath, et al.
Published: (2024)